Synthetic vaccine against foot and mouth disease based on a palmitoyl derivative of the VP1 protein 135-159 fragment of the A22 virus strain

Vaccine

Volumn 14, Issue 14, 1996, Pages 1375-1380

  Volpina, O M ^a   Yarov, A V ^a   Zhmak, M N ^a   Kuprianova, M A ^a   Chepurkin, A V ^b   Toloknov, A S ^b   Ivanov, V T ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b Federal Centre for Animal Health (FGI ARRIAH)   (Russian Federation)

Author keywords

Foot and mouth disease; peptide vaccine; Veterinary use

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; PEPTIDE VACCINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RUSSIAN FEDERATION; SHEEP; VACCINATION; VETERINARY MEDICINE;

ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; FEMALE; FOOT-AND-MOUTH DISEASE; GUINEA PIGS; MICE; MICE, INBRED STRAINS; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; SHEEP; VACCINES, SYNTHETIC;

EID: 0030267841     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00038-2     Document Type: Article

References (17)

1. 1 Bittle, J.L., Houghten, R.A., Alexander, H. et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982, 298, 30-33
2. 2 Pfaff, E., Mussgay, M., Bohm, H.O., Schulz, G.E. and Shaller, H. Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J 1982, 1, 869-874
3. 3 Mulcahy, G., Gale, C., Robertson, P., Iyisan, S., DiMarchi, R.D. and Doel, T.R. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 1990, 8, 249-256
4. 4 Jolivet, M., Lise, L., Gras-Masse, H., Tartar, A., Audibert, F. and Chedid, L. Polivalent synthetic vaccines: relationship between T epitopes and immunogenicity. Vaccine 1990, 8, 35-40
5. 5 Francis, M.J., Hastings, G.Z., Syred, A.D., McGinn, B., Brown, F. and Rowlands, D.J. Nonresponsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 1987, 330, 168-170
6. 6 Wunsch, E., Moroder, L., Hurbener, G. et al. Fully synthetic immunogen. Part III. Synthesis of hinge-peptide/gastrin conjugates and their immunological properties. Int. J. Pept. Protein Res. 1991, 37, 90-102
7. 7 Wiesmuller, K.-H., Jung, G. and Hess, G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophaghe activator. Vaccine 1989, 7, 29-33
8. 8 Rouaix, F., Gras-Masse, H., Mazingue, C. et al. Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T-cells. Vaccine 1994, 12, 1209-1214
9. 9 Mitchell, A.R., Kent, S.B.H., Engelgard, M. and Merrifield, R.B. A new synthetic route to tert-butyloxycarbonylacetamidomethylresin, an improved support for solid-phase peptide synthesis. J. Org. Chem. 1978, 43, 2845-2852
10. 10 Tam, J.P., Heath, W.F. and Merrifield, R.B. SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J. Am. Chem. Soc. 1983, 105, 6442-6455
11. 11 Surovoy, A.Yu., Gelfanov, V.M., Volpina, O.M. et al. Antigenic structure of foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides covering the sequence of immunodominant region of VP1 protein O1K and A22 strains of foot-and-mouth disease virus. Bioorgan. Khim. 1989, 15, 1185-1192 (in Russian)
12. 12 Patent SU 1615917 A1, A 61 K 39/135
13. 13 Patent SU 1797204 A1, A 61 K 39/135
14. 14 Yarov, A.V. , Gelfanov, V.M., Grechaninova, L.A. et al. Antigenic structure of foot-and-mouth disease virus. V. Protection of susceptible animals with the use of a synthetic peptide. Bioorgan. Khim. 1989, 15, 1313-1317 (in Russian)
15. 15 Gelfanov, V.M., Grechaninova, L.A., Kan, E.S. et al. Antigenic structure of foot-and-mouth disease virus. VI. Functional sites of the immunodominant region of VP1 protein of the foot-and-mouth disease virus O1K and A22 strains. Bioorgan. Khim. 1991, 17, 596-605 (in Russian)
16. 16 Volpina, O.M., Gelfanov, V.M., Yarov, A.V., Surovoy, A.Yu., Chepurkin, A.V. and Ivanov, V.T. New virus specific epitopes of foot-and-mouth disease viral VP1 protein. FEBS Lett. 1993, 333, 175-178
17. 17 Andronova, T. and Ivanov, V. The structure and immunomodulating function of glucosaminylmuramyl peptides. In: Sov. Medical Review D. Immunology Vol. 4 (Ed. Petrov, R.). Harwood Academic Publishers, United Kingdom, 1991, pp. 1-63